Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis
- PMID: 33453617
- PMCID: PMC7832118
- DOI: 10.1016/j.ajem.2021.01.006
Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis
Abstract
Background: The neutrophil-to-lymphocyte ratio (NLR), an inflammatory marker, was suggested to be predictive of severity and mortality in COVID-19 patients. Here, we investigated whether NLR levels on admission could predict the severity and mortality of COVID-19 patients.
Methods: A literature search was conducted on 23 July 2020 to retrieve all published articles, including grey literature and preprints, investigating the association between on-admission NLR values and severity or mortality in COVID-19 patients. A meta-analysis was performed to determine the overall standardized mean difference (SMD) in NLR values and the pooled risk ratio (RR) for severity and mortality with the 95% Confidence Interval (95%CI).
Results: A total of 38 articles, including 5699 patients with severity outcomes and 6033 patients with mortality outcomes, were included. The meta-analysis showed that severe and non-survivors of COVID-19 had higher on-admission NLR levels than non-severe and survivors (SMD 0.88; 95%CI 0.72-1.04; I2 = 75.52% and 1.87; 95%CI 1.25-2.49; I2 = 97.81%, respectively). Regardless of the different NLR cut-off values, the pooled mortality RR in patients with elevated vs. normal NLR levels was 2.74 (95%CI 0.98-7.66).
Conclusion: High NLR levels on admission were associated with severe COVID-19 and mortality. Further studies need to focus on determining the optimal cut-off value for NLR before clinical use.
Keywords: COVID-19; Meta-analysis; Mortality; Neutrophil-to-lymphocyte ratio; Severity.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Neutrophil-to-lymphocyte ratio as a prognostic indicator in COVID-19: Evidence from a northern tanzanian cohort.PLoS One. 2025 Jan 31;20(1):e0300231. doi: 10.1371/journal.pone.0300231. eCollection 2025. PLoS One. 2025. PMID: 39888959 Free PMC article.
-
Does Neutrophil-to-lymphocyte Ratio at Admission Predict Severity and Mortality in COVID-19 Patients? A Systematic Review and Meta-analysis.Indian J Crit Care Med. 2022 Mar;26(3):361-375. doi: 10.5005/jp-journals-10071-24135. Indian J Crit Care Med. 2022. PMID: 35519918 Free PMC article.
-
The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.Saudi Med J. 2021 Apr;42(4):370-376. doi: 10.15537/smj.2021.42.4.20200818. Saudi Med J. 2021. PMID: 33795491 Free PMC article.
-
The Impact of Neutrophil-Lymphocyte Count Ratio in COVID-19: A Systematic Review and Meta-Analysis.J Intensive Care Med. 2022 Jul;37(7):857-869. doi: 10.1177/08850666211045626. Epub 2021 Oct 21. J Intensive Care Med. 2022. PMID: 34672824 Free PMC article.
-
The Role of Neutrophil-to-Lymphocyte Ratio in Risk Stratification and Prognostication of COVID-19: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2022 Aug 1;10(8):1233. doi: 10.3390/vaccines10081233. Vaccines (Basel). 2022. PMID: 36016121 Free PMC article. Review.
Cited by
-
The role of the neutrophil-lymphocyte ratio in predicting poor outcomes in COVID-19 patients.Cardiol J. 2024;31(3):374-380. doi: 10.5603/cj.98214. Epub 2023 Dec 27. Cardiol J. 2024. PMID: 38149489 Free PMC article.
-
The Value of Early and Follow-Up Elevated Scores Based on Peripheral Complete Blood Cell Count for Predicting Adverse Outcomes in COVID-19 Patients.J Pers Med. 2022 Dec 9;12(12):2037. doi: 10.3390/jpm12122037. J Pers Med. 2022. PMID: 36556258 Free PMC article.
-
Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection.Sci Rep. 2021 Nov 2;11(1):21519. doi: 10.1038/s41598-021-00927-x. Sci Rep. 2021. PMID: 34728719 Free PMC article.
-
Association Between Neutrophil-Lymphocyte Ratio and Gestational Diabetes-A Systematic Review and Meta-Analysis.J Endocr Soc. 2021 Mar 23;5(7):bvab051. doi: 10.1210/jendso/bvab051. eCollection 2021 Jul 1. J Endocr Soc. 2021. PMID: 34095691 Free PMC article. Review.
-
Leukocyte ratios are useful early predictors for adverse outcomes of COVID-19 infection.Rev Inst Med Trop Sao Paulo. 2022 Nov 14;64:e73. doi: 10.1590/S1678-9946202264073. eCollection 2022. Rev Inst Med Trop Sao Paulo. 2022. PMID: 36383895 Free PMC article.
References
-
- World Health Organization WHO Coronavirus Disease (COVID-19) 2020. https://covid19.who.int/ Dashboard.
-
- Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R. StatPearls; Treasure Island (FL): 2020. Features, evaluation and treatment coronavirus (COVID-19) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical